Geron Corp. Company Profile (NASDAQ:GERN)

About Geron Corp.

Geron Corp. logoGeron Corporation (Geron) is a biopharmaceutical company, which supports the clinical stage development of a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies by Janssen Biotech, Inc. (Janssen). The Company operates through the segment, which includes discovery and development of therapeutic products for oncology. Imetelstat is a lipid conjugated 13-mer oligonucleotide that is designed to be complementary to and bind with high affinity to the ribonucleic acid (RNA) template of telomerase, thereby directly inhibiting telomerase activity. Imetelstat exhibits relatively preferential inhibition of the clonal proliferation of malignant progenitor cells in nonclinical studies. Janssen is engaged in the development of Imetelstat with over two clinical trials, such as a Phase II trial in myelofibrosis (MF), referred to as IMbark, and a Phase II/III trial in myelodysplastic syndromes (MDS) referred to as IMerge.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GERN
  • CUSIP: 37416310
Key Metrics:
  • Previous Close: $2.20
  • 50 Day Moving Average: $2.58
  • 200 Day Moving Average: $2.78
  • 52-Week Range: $1.84 - $5.30
  • Trailing P/E Ratio: 272.50
  • Foreward P/E Ratio: -55.25
  • P/E Growth: -1.93
  • Market Cap: $346.92M
  • Outstanding Shares: 159,139,000
  • Beta: 2.63
Profitability:
  • Net Margins: 3.39%
  • Return on Equity: 0.89%
  • Return on Assets: 0.85%
Debt:
  • Current Ratio: 15.71%
  • Quick Ratio: 15.71%
Additional Links:
Companies Related to Geron Corp.:

Analyst Ratings

Consensus Ratings for Geron Corp. (NASDAQ:GERN) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $5.50 (148.87% upside)

Analysts' Ratings History for Geron Corp. (NASDAQ:GERN)
Show:
DateFirmActionRatingPrice TargetDetails
9/22/2016FBR & CoReiterated RatingOutperform$5.00View Rating Details
9/20/2016BTIG ResearchReiterated RatingNeutralView Rating Details
9/13/2016Piper Jaffray Cos.Reiterated RatingOverweight$10.00 -> $5.00View Rating Details
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$6.50View Rating Details
12/7/2015Oppenheimer Holdings Inc.Reiterated RatingBuy$5.50View Rating Details
8/10/2015MLV & Co.Reiterated RatingBuy$6.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Geron Corp. (NASDAQ:GERN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/3/2016Q216($0.07)($0.05)$0.38 million$0.21 millionViewListenView Earnings Details
5/5/2016Q116($0.06)($0.06)$0.26 million$0.74 millionViewListenView Earnings Details
2/25/2016Q415($0.05)($0.05)$0.32 million$0.22 millionViewListenView Earnings Details
11/5/2015Q315$0.12$0.17$17.87 million$35.40 millionViewListenView Earnings Details
8/5/2015Q2 15($0.06)($0.05)$0.40 million$0.25 millionViewN/AView Earnings Details
4/30/2015Q1($0.06)($0.06)$0.32 million$0.54 millionViewN/AView Earnings Details
3/3/2015Q4$0.17($0.06)$35.35 million$0.18 millionViewListenView Earnings Details
11/3/2014Q314($0.06)($0.06)ViewN/AView Earnings Details
8/11/2014Q214($0.06)($0.06)$0.22 million$0.34 millionViewListenView Earnings Details
5/1/2014Q114($0.06)($0.06)$0.35 million$0.47 millionViewListenView Earnings Details
3/27/2014($0.06)($0.07)ViewN/AView Earnings Details
3/17/2014Q413($0.07)($0.07)$0.35 millionViewListenView Earnings Details
11/7/2013Q313($0.06)($0.06)$0.49 million$0.18 millionViewListenView Earnings Details
8/8/2013Q2 2013($0.07)($0.07)$0.50 million$0.11 millionViewListenView Earnings Details
4/25/2013Q1 2013($0.08)($0.09)$0.71 million$0.77 millionViewListenView Earnings Details
3/12/2013Q4 2012($0.14)($0.12)$0.50 million$0.69 millionViewListenView Earnings Details
10/30/2012Q312($0.14)($0.13)$0.38 million$0.64 millionViewN/AView Earnings Details
7/31/2012($0.15)($0.14)ViewN/AView Earnings Details
5/2/2012($0.18)($0.15)ViewN/AView Earnings Details
11/3/2011($0.18)($0.16)ViewN/AView Earnings Details
7/28/2011($0.18)($0.17)ViewN/AView Earnings Details
4/27/2011($0.19)($0.20)ViewN/AView Earnings Details
2/24/2011($0.19)($0.39)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Geron Corp. (NASDAQ:GERN)
Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS

Dividends

Dividend History for Geron Corp. (NASDAQ:GERN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Geron Corp. (NASDAQ:GERN)
Insider Ownership Percentage: 5.82%
Institutional Ownership Percentage: 38.09%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/29/2015Olivia Kyusuk BloomCFOSell2,380$3.84$9,139.20View SEC Filing  
3/18/2015Thomas HofstaetterDirectorSell70,000$4.10$287,000.00View SEC Filing  
5/29/2014Melissa Kelly BehrsEVPSell4,826$2.10$10,134.60View SEC Filing  
5/29/2014Olivia Kyusuk BloomCFOSell3,379$2.10$7,095.90View SEC Filing  
5/9/2014Daniel BradburyDirectorBuy142,776$1.75$249,858.00View SEC Filing  
4/1/2014Melissa Kelly BehrsEVPSell12,310$2.13$26,220.30View SEC Filing  
4/1/2014Olivia Kyusuk BloomCFOSell7,435$2.13$15,836.55View SEC Filing  
4/1/2013John A ScarlettCEOBuy50,000$1.03$51,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Geron Corp. (NASDAQ:GERN)
DateHeadline
News IconAnalysts Review: Geron Corporation (NASDAQ:GERN), Fairmount Santrol Holdings Inc. (NYSE:FMSA) - Newburgh Press (NASDAQ:GERN)
newburghpress.com - September 26 at 9:54 AM
investopedia.com logoGlobal Licensing Deal Spikes Geron Stock (GERN, JNJ) (NASDAQ:GERN)
www.investopedia.com - September 24 at 9:46 AM
News IconKeen Investors Find News on Geron Corporation (NASDAQ:GERN) - Duncan Research (NASDAQ:GERN)
www.duncanindependent.com - September 23 at 4:54 PM
News IconBiotech Companies To Look Out For: Medivation, Inc. (MDVN), Geron Corporation (GERN) - The Independent Republic (NASDAQ:GERN)
theindependentrepublic.com - September 23 at 10:11 AM
News IconGeron Corporation (NASDAQ:GERN) Performance Overview - Newburgh Press (NASDAQ:GERN)
newburghpress.com - September 22 at 10:45 AM
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation (NASDAQ:GERN), Spectrum Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:GERN)
voiceregistrar.com - September 22 at 10:45 AM
News IconPenny Stock Investors Keen on Shares of Geron Corporation (NASDAQ:GERN) - Duncan Research (NASDAQ:GERN)
www.duncanindependent.com - September 21 at 5:40 PM
News IconActive Biotech Stock News: Geron Corporation (GERN), MannKind Corp. (MNKD) - The Independent Republic (NASDAQ:GERN)
theindependentrepublic.com - September 21 at 9:25 AM
biz.yahoo.com logoGERON CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:GERN)
biz.yahoo.com - September 21 at 9:25 AM
thestreet.com logoGeron (GERN) Stock Rises on $80 Million Janssen Licensing Deal (NASDAQ:GERN)
www.thestreet.com - September 21 at 9:25 AM
streetinsider.com logoGeron Corp (GERN), Janssen Pharma Enter Exclusive Licensing Agreement - StreetInsider.com (NASDAQ:GERN)
www.streetinsider.com - September 20 at 10:20 AM
seekingalpha.com logoGeron inks license deal with Janssen Pharma valued up to $80M (NASDAQ:GERN)
seekingalpha.com - September 19 at 11:44 AM
streetinsider.com logoGeron Corp (GERN), Janssen Pharma Enter Exclusive Licensing Agreement (NASDAQ:GERN)
www.streetinsider.com - September 19 at 9:48 AM
News IconKeen Investors Seek Information on Geron Corporation (NASDAQ:GERN) - Duncan Research (NASDAQ:GERN)
www.duncanindependent.com - September 16 at 5:02 PM
News IconBiotech stocks for your portfolio: Vertex Pharmaceuticals Incorporated (VRTX), Geron Corporation (GERN) - National Daily Press (NASDAQ:GERN)
www.nationaldailypress.com - September 16 at 9:01 AM
seekingalpha.com logoGeron: Uncertainties Abound In Imetelstat Clinical Trial - Seeking Alpha (NASDAQ:GERN)
seekingalpha.com - September 16 at 9:01 AM
finance.yahoo.com logobluebird bio (BLUE) in Focus: Stock Moves 11.4% Higher (NASDAQ:GERN)
finance.yahoo.com - September 16 at 9:01 AM
seekingalpha.com logoGeron: Uncertainties Abound In Imetelstat Clinical Trial (NASDAQ:GERN)
seekingalpha.com - September 15 at 5:33 PM
capitalcube.com logoGeron Corp. – Value Analysis (NASDAQ:GERN) : September 14, 2016 (NASDAQ:GERN)
www.capitalcube.com - September 14 at 5:18 PM
finance.yahoo.com logoGeron (GERN) at 52-Week Low on Imetelstat Study Update (NASDAQ:GERN)
finance.yahoo.com - September 14 at 9:27 AM
investopedia.com logoGeron Corp.’s Results Lead 23% Fall (GERN) (NASDAQ:GERN)
www.investopedia.com - September 14 at 9:27 AM
capitalcube.com logoGeron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : September 13, 2016 (NASDAQ:GERN)
www.capitalcube.com - September 13 at 9:59 AM
feeds.benzinga.com logoMid-Afternoon Market Update: Dow Surges Over 200 Points; Geron Shares Tumble (NASDAQ:GERN)
feeds.benzinga.com - September 12 at 2:32 PM
News IconIs Geron Being Overly Punished? (NASDAQ:GERN)
feedproxy.google.com - September 12 at 1:46 PM
fool.com logoWhy Geron Corporation Is Plunging Today (NASDAQ:GERN)
www.fool.com - September 12 at 1:45 PM
seekingalpha.com logoGeron down 27% premarket on uncertainties in imetelstat studies (NASDAQ:GERN)
seekingalpha.com - September 12 at 10:17 AM
nasdaq.com logoGeron Updates On Imetelstat Trials Being Conducted By Janssen R&D (NASDAQ:GERN)
www.nasdaq.com - September 12 at 10:00 AM
streetinsider.com logoGeron Corp (GERN) Notes Janssen Imetelstat Trials Continuing (NASDAQ:GERN)
www.streetinsider.com - September 12 at 10:00 AM
publicnow.com logoGeron Provides Update on Imetelstat Trials Being Conducted by Janssen (NASDAQ:GERN)
www.publicnow.com - September 12 at 10:00 AM
finance.yahoo.com logo3 Reasons Why Geron (GERN) is a Great Momentum Stock (NASDAQ:GERN)
finance.yahoo.com - September 12 at 10:00 AM
News IconStocks Ride on Analysts Coverage- Medtronic (NYSE:MDT), Geron ... - Seneca Globe (NASDAQ:GERN)
www.senecaglobe.com - September 11 at 9:36 AM
publicnow.com logoGeron Announces Conference Call on September 12 at 8:00 A.M. Eastern Time (NASDAQ:GERN)
www.publicnow.com - September 11 at 9:36 AM
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation (NASDAQ:GERN), Celgene Corporation (NASDAQ:CELG) - The Voice Registrar (NASDAQ:GERN)
voiceregistrar.com - September 9 at 5:01 PM
News IconTrading the Biotech News: Geron Corporation (NASDAQ:GERN), Amicus Therapeutics, Inc. (NASDAQ:FOLD) - The Voice Registrar (NASDAQ:GERN)
voiceregistrar.com - September 9 at 9:56 AM
finance.yahoo.com logoCan the Rally in Geron (GERN) Shares Continue? (NASDAQ:GERN)
finance.yahoo.com - September 8 at 5:03 PM
finance.yahoo.com logoLigand/Retrophin Rare Disease Drug Positive in Phase II (NASDAQ:GERN)
finance.yahoo.com - September 8 at 9:02 AM
finance.yahoo.com logoMerck Stops Development of Odanacatib for Osteoporosis (NASDAQ:GERN)
finance.yahoo.com - September 5 at 9:41 AM
News IconGeron Corporation's (GERN): Volatile Stock to Watch - Hot Stocks Point (NASDAQ:GERN)
www.hotstockspoint.com - September 1 at 8:05 AM
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation (NASDAQ:GERN), Portola Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:GERN)
voiceregistrar.com - August 31 at 9:57 AM
News IconNoteworthy Monday Option Activity: GM, GERN, DSW (NASDAQ:GERN)
www.stockoptionschannel.com - August 29 at 5:05 PM
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation ... - The Voice Registrar (NASDAQ:GERN)
voiceregistrar.com - August 28 at 9:38 AM
biz.yahoo.com logoGERON CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:GERN)
biz.yahoo.com - August 25 at 5:12 PM
News Icon2 Biotech Stocks News And Price Trends: Geron Corporation (NASDAQ:GERN), ZIOPHARM Oncology, Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:GERN)
voiceregistrar.com - August 25 at 10:12 AM
capitalcube.com logoGeron Corp. breached its 50 day moving average in a Bearish Manner : GERN-US : August 25, 2016 (NASDAQ:GERN)
www.capitalcube.com - August 25 at 10:12 AM
finance.yahoo.com logoMylan (MYL) Obtains Favorable USPTO Ruling for Copaxone (NASDAQ:GERN)
finance.yahoo.com - August 25 at 10:12 AM
finance.yahoo.com logoClovis (CLVS) Stock Up on FDA Priority Review for Rucaparib (NASDAQ:GERN)
finance.yahoo.com - August 24 at 8:13 AM
zacks.com logoAlder Biopharmaceuticals (ALDR) Jumps: Stock Rises 9.6% (NASDAQ:GERN)
www.zacks.com - August 23 at 5:21 PM
zacks.com logoGilead (GILD) Truvada Gets EU Approval for Label Expansion (NASDAQ:GERN)
www.zacks.com - August 23 at 9:35 AM
News IconLet's Take a Closer Look at Geron Corporation (NASDAQ:GERN) - Duncan Research (NASDAQ:GERN)
www.duncanindependent.com - August 22 at 5:16 PM
finance.yahoo.com logoPfizer's (PFE) Pain Drug Troxyca ER Receives FDA Approval (NASDAQ:GERN)
finance.yahoo.com - August 22 at 9:50 AM

Social

Geron Corp. (NASDAQ:GERN) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff